Umb Bank, N.A. Aerie Pharmaceuticals Inc Transaction History

Umb Bank, N.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 18, 2021	SELL	$11.32 - $16.63 $113,200 - $166,300	-10,000 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$9.12 - $14.49 $820 - $1,304	-90 Reduced 0.89%	10,000 $135,000
Q2 2020 Jul 16, 2020	SELL	$12.0 - $16.13 $180 - $241	-15 Reduced 0.15%	10,090 $149,000
Q2 2019 Jul 30, 2019	BUY	$28.97 - $48.21 $292,741 - $487,162	10,105 New	10,105 $299,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

Stay updated on Umb Bank, N.A. with notifications on news.